Product information and disease descriptionProduct descriptionProduct information
Access and distribution
4 evidence topics · 7 sources
Commercial preparation for a United States launch
Manufacturing, packaging, and distribution
Expanded access program in the United States (NCT07759141)
Continued investigational access through the RAPIDe-2 open-label extension
Specialty pharmacy or limited distribution arrangements
No evidence found.